Pharma

Go sign green light

Pharma

Handa's Cabometyx formulation no threat to Exelixis: analysts

Still, various factors mean the nod for Handa’s Cabometyx reformulation is unlikely to pose a threat to Exelixis, analysts have said.

Fraiser Kansteiner Sep 11, 2026 2:06pm

showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Novo, Lilly obesity pills grow scripts

Sep 11, 2026 10:15am

Podcast

Top Line Podcast - ZS

Designing an agentic, future‑ready tech roadmap for emerging pharma

Brought to you by ZS

Asia

Takeda, Daiichi, Samsung Bio and more—Fierce Pharma Asia

Sep 11, 2026 9:15am

video

Pharma marketers face privacy hurdles turn to omnichannel strategies

Pharma marketers face privacy hurdles, turn to omnichannel strategies

Brought to you by Swoop

Graphic of two hands shaking under a red and purple light

CDMO Argonaut sells of life sci and diagnostics division

Sep 11, 2026 8:33am